Free sample with qualifying order

Your trusted seller since 2003

  • SKINCEUTICALS MICROPEEL 30 | Advanced Unbuffered Glycolic Acid Resurfacing & Chemoexfoliation Matrix

SKINCEUTICALS MICROPEEL 30 | Advanced Unbuffered Glycolic Acid Resurfacing & Chemoexfoliation Matrix

Item #: skinceuticals-micropeel-30

Price: $269.00

Availability: In Stock

Qty:


The SkinCeuticals Micropeel 30 is a medical-grade, high-performance in-office professional superficial chemical peeling treatment solution meticulously engineered to maximize epidermal cellular turnover, eradicate advanced hyperkeratotic accumulation, and optimize global cellular skin longevity. Calibrated strictly for clinical administration by licensed healthcare professionals, this maximum-strength, low-viscosity liquid exfoliant deploys a highly active 30% concentration of pure unbuffered Glycolic Acid (Alpha-Hydroxy Acid). Operating as an intensive texturizing and corrective vehicle, its ultra-small molecular footprint dynamically breaks down the desmosomal bonds pinning dense, dead, and hyperpigmented keratinocytes to the stratum corneum—unveiling an exceptionally sleek, tonally uniform, and deeply revitalized skin canvas with minimal downtime.

PRODUCT SPECIFICATIONS & PACKAGING INCLUSIONS

• 1 x SkinCeuticals Micropeel 30 Professional Solution (2 fl oz / 60ml): A clinically calibrated unbuffered liquid chemoexfoliant packaged within a professional, high-integrity amber glass backbar bottle featuring an acid-resistant dropper assembly engineered to insulate the active maximum-strength free-acid matrix from premature atmospheric or light-driven degradation.

____________________________________________________________________________________________________________________________________________________________________________

KEY TECHNICAL SPECIFICATIONS & BENEFITS

• Deploys a Maximum-Strength Unbuffered 30% Glycolic Acid Payload operating at a highly active, low-pH baseline to maximize free-acid bio-availability and achieve the deepest possible superficial desquamation.

• Harnesses a Low-Viscosity, Ultra-Small Molecular Structure that effortlessly floods the epidermal sheets to rapidly sweep away thick, stubborn, sallow dead cell accumulation.

• Significantly Diminishes Advanced Fine Lines and Moderate Mechanical Wrinkles by forcing rapid cellular renewal and stimulating the biosynthetic pathways of the underlying dermal matrix.

• Eradicates Severe Superficial Pigmentary Staining, accelerating the removal of heavily melanized surface layers to clear chronic post-inflammatory hyperpigmentation (PIH), solar lentigines, and melasma.

• Visibly Clears and Compresses Extruded Pore Outlines, lifting the hardened keratinous plugs that structurally stretch, expand, and distort follicular walls.

• Functions as an Absolute Penetration Primer, removing the dense cellular shield to radically amplify the transdermal migration and bio-availability of subsequent clinical active topicals.

____________________________________________________________________________________________________________________________________________________________________________

PRIMARY INDICATIONS & USE CASES

• Mature, photo-damaged, and lackluster skin landscapes exhibiting advanced signs of aging, deep micro-textural roughness, and localized environmental staining.

• Skin profiles that have successfully completed a Micropeel 20 cycle and require the maximum free-acid percentage to drive deeper, more profound epidermal remodeling.

• Complexions marred by persistent sallow dullness, uneven light-reflection, and resistant dark spots left behind by healed acne lesions or sun exposure.

• In-office clinical administration safe for comprehensive deployment across universal Fitzpatrick phototypes (I-VI) with mandatory professional pre-conditioning.

____________________________________________________________________________________________________________________________________________________________________________

FREQUENTLY ASKED QUESTIONS

Q: What makes the unbuffered 30% Glycolic Acid inside Micropeel 30 more effective than higher-percentage buffered retail peels?

A: The clinical efficacy of an alpha-hydroxy acid peel is governed by its free-acid availability and pH baseline, not merely the raw percentage stated on the packaging. Many consumer retail chemical peels are heavily buffered, which raises the formula's pH and neutralizes the active acid molecules, rendering them passive. SkinCeuticals Micropeel 30 features a completely unbuffered liquid platform. This optimization ensures that the entire 30% glycolic payload remains fully bio-available to immediately target surface hyperkeratosis upon contact, delivering a predictable cellular renewal that easily outperforms higher-percentage, buffered alternatives.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Q: How does Micropeel 30 conclude the step-up professional unbuffered glycolic acid peeling hierarchy?

A: Micropeel 30 serves as the definitive maximum-strength step in the professional unbuffered glycolic acid peeling series (progressing from Micropeel 15 to 20, and finally Micropeel 30). While Micropeel 15 and 20 are optimized to establish baseline acid tolerance and address moderate imperfections, Micropeel 30 steps up the intensity to target the most deep-seated photoaging, rougher textures, and stubborn hyperpigmentation. It allows the clinician to achieve maximum cellular turnover and dermal stimulation in skin that has already been thoroughly conditioned to tolerate this advanced level of free glycolic acid.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Q: What is the expected skin-shedding cascade and clinical downtime following a Micropeel 30 session?

A: Because Micropeel 30 targets the upper layers of the epidermis, it is classified as a controlled superficial treatment with exceptionally low downtime, despite its maximum strength. Patients will experience mild to moderate, transient erythema (redness) and localized warmth for 2 to 24 hours post-procedure. Rather than shedding in heavy, unmanageable sheets, the skin will undergo a manageable micro-flaking or dry powder-like peeling phase starting around day 2 or 3. This shedding cascade typically self-neutralizes cleanly by day 5 to 7, revealing a completely smooth, bright, and luminous skin canvas.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Q: Is Micropeel 30 safe to deploy on darker Fitzpatrick phototypes (V-VI) without inducing rebound dark spots?

A: Yes, exceptionally well, provided strict clinical pre-conditioning protocols are enforced. Darker skin profiles possess highly active melanocytes that can easily overreact to erratic or aggressive chemical trauma, leading to post-inflammatory hyperpigmentation (PIH). The 30% concentration provides a highly controlled, progressive treatment depth that gently resurfaces the tissue without shocking underlying pigment cells. However, patients with Fitzpatrick phototypes V and VI must pre-condition their skin barrier for 2 to 4 weeks prior to the peel with a daily SkinCeuticals antioxidant and pigment regulator to fully sedate melanocytes.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Q: What is the mathematically precise application and neutralization protocol for this clinical peel?

A: This solution must be applied strictly according to professional clinical guidelines. Following a thorough dual-cleansing and degreasing step, the clinician saturates a professional gauze pad or cotton swab with the Micropeel 30 liquid. The solution is applied quickly and evenly across the facial matrix, avoiding the immediate eye contours and lip margins. The solution must be timed precisely and left undisturbed for exactly 2 to 5 minutes, depending on the patient's structural skin thickness and neuro-sensory feedback. The peel is not self-limiting; therefore, it must be completely deactivated using a dedicated sodium bicarbonate neutralizer or copious amounts of cool water until all tingling sensations cease entirely. Conclude with a recovery balm and a 100% mineral sunscreen.